Related references
Note: Only part of the references are listed.The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis
Robert A. McCutcheon et al.
MOLECULAR PSYCHIATRY (2021)
A systematic review of genome-wide association studies of antipsychotic response
Josiah D. Allen et al.
PHARMACOGENOMICS (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up
Heidi Taipale et al.
SCHIZOPHRENIA BULLETIN (2018)
Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
Miriam Saiz-Rodriguez et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Recent Progress in Pharmacogenomics of Antipsychotic Drug Response
Jian-Ping Zhang et al.
CURRENT PSYCHIATRY REPORTS (2018)
Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients
Wei Zhou et al.
NEUROSCIENCE LETTERS (2018)
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
E. Sacchetti et al.
PHARMACOGENOMICS JOURNAL (2017)
Measuring global health: motivation and evolution of the Global Burden of Disease Study
Christopher J. L. Murray et al.
LANCET (2017)
A null mutation in TNIK defines a novel locus for intellectual disability
Shams Anazi et al.
HUMAN GENETICS (2016)
Organization of TNIK in dendritic spines
Alain C. Burette et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2015)
The contribution of de novo coding mutations to autism spectrum disorder
Ivan Iossifov et al.
NATURE (2014)
Association Study of 27 Annotated Genes for Clozapine Pharmacogenetics Validation of Preexisting Studies and Identification of a New Candidate Gene, ABCB1, for Treatment Response
Seung-Tae Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
TNiK Is Required for Postsynaptic and Nuclear Signaling Pathways and Cognitive Function
Marcelo P. Coba et al.
JOURNAL OF NEUROSCIENCE (2012)
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
M. Ayalew et al.
MOLECULAR PSYCHIATRY (2012)
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder
Josephine Elia et al.
NATURE GENETICS (2012)
Knockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro
Erik J. MacLaren et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
MINK and TNIK Differentially Act on Rap2-Mediated Signal Transduction to Regulate Neuronal Structure and AMPA Receptor Function
Natasha K. Hussain et al.
JOURNAL OF NEUROSCIENCE (2010)
Identifying gene regulatory networks in schizophrenia
Steven G. Potkin et al.
NEUROIMAGE (2010)
Regulation of Rap2A by the Ubiquitin Ligase Nedd4-1 Controls Neurite Development
Hiroshi Kawabe et al.
NEURON (2010)
Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation
Maureen V. Martin et al.
BMC MEDICAL GENOMICS (2009)
Common variants on chromosome 6p22.1 are associated with schizophrenia
Jianxin Shi et al.
NATURE (2009)
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
B. A. Fijal et al.
PHARMACOGENOMICS JOURNAL (2009)
A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype
Steven G. Potkin et al.
SCHIZOPHRENIA BULLETIN (2009)
Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway
N. Matigian et al.
MOLECULAR PSYCHIATRY (2007)
Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients
Qinghe Xing et al.
PHARMACOGENOMICS (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton
K Taira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Risperidone treatment in children and adolescents with autism: Short- and long-term safety and effectiveness
RP Malone et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)